ID
35513
Description
Study ID: 101468/194 Clinical Study ID: 101468/194 Study Title: A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS). Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 3/6/19 3/6/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
March 6, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Ropinirole in Patients with Restless Legs Syndrome (Study ID: 101468/194)
Form D
- StudyEvent: ODM
Description
Form D
Alias
- UMLS CUI-1
- C0011065
Description
Cause of Death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Date of Death
Data type
date
Alias
- UMLS CUI [1]
- C1148348
Description
Autopsy
Data type
boolean
Alias
- UMLS CUI [1]
- C0004398
Description
Autopsy, Findings, Diagnosis
Data type
text
Alias
- UMLS CUI [1,1]
- C0004398
- UMLS CUI [1,2]
- C0243095
- UMLS CUI [1,3]
- C0011900
Description
Signature of responsible attending physician on file
Data type
text
Alias
- UMLS CUI [1]
- C0807938
Description
Signature of responsible attending physician on file, Date in time
Data type
date
Alias
- UMLS CUI [1,1]
- C0807938
- UMLS CUI [1,2]
- C0011008
Similar models
Form D
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,2])
C0011900 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])